Zimmer Biomet Holdings (ZBH) Gross Margin (2009 - 2026)
Zimmer Biomet Holdings' (ZBH) quarterly Gross Margin came in at 72.39% in Q1 2026, up 119.0% year-on-year from 33.05% in Q1 2025, and up 11.91% quarter-over-quarter from 64.68% in Q4 2025.
Zimmer Biomet Holdings (ZBH) Gross Margin (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Gross Margin history runs 18 years deep, the most recent figure standing at 72.39% for Q1 2026.
- On a quarterly basis, Gross Margin rose 119.0% year-over-year to 72.39% in Q1 2026; TTM through Mar 2026 was 70.03%, a 102.0% decrease from a year earlier, with the FY2025 full-year figure at 69.71%, down 176.0% from the prior year.
- Gross Margin advanced to 72.39% in Q1 2026 per ZBH's latest filing, from 64.68% in the prior quarter.
- Across five years, Gross Margin topped out at 72.88% in Q1 2024 and bottomed at 64.68% in Q4 2025.
- The 5-year median for Gross Margin is 71.49% (2025), against an average of 71.08%.
- Across the five-year window, Gross Margin surged 271 bps in 2023 and sank 632 bps in 2025, its largest moves.
- Year by year, Gross Margin stood at 71.49% in 2022, then gained by 1 bps to 72.23% in 2023, then slipped by 2 bps to 71.0% in 2024, then decreased by 9 bps to 64.68% in 2025, then increased by 12 bps to 72.39% in 2026.
- Per Business Quant, the three latest ZBH Gross Margin figures stand at 72.39% (Q1 2026), 64.68% (Q4 2025), and 72.05% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 78.01% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 62.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 45.22% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 38.53% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Zimmer Biomet Holdings | 17.48 Bn | 17.07 Bn | 1.51 Bn | 72.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72.39% |
| Dec 31, 2025 | 64.68% |
| Sep 30, 2025 | 72.05% |
| Jun 30, 2025 | 71.49% |
| Mar 31, 2025 | 71.20% |
| Dec 31, 2024 | 71.00% |
| Sep 30, 2024 | 70.47% |
| Jun 30, 2024 | 71.49% |
| Mar 31, 2024 | 72.88% |
| Dec 31, 2023 | 72.23% |
| Sep 30, 2023 | 70.43% |
| Jun 30, 2023 | 71.89% |
| Mar 31, 2023 | 72.65% |
| Dec 31, 2022 | 71.49% |
| Sep 30, 2022 | 70.76% |
| Jun 30, 2022 | 71.32% |
| Mar 31, 2022 | 69.94% |
| Dec 31, 2021 | 69.81% |
| Sep 30, 2021 | 70.84% |
| Jun 30, 2021 | 71.86% |